BioRestorative Therapies, Inc. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-19.9% -$461K
$-3M
Free Cash Flow↓-540.7% -$67K
$-80K
Investing Cash Flow↑+56.6% +$868K
$2M
Financing Cash Flow
$923K
Capex↑+540.7% +$67K
$80K
Stock Buybacks
$0
Stock-Based Comp↑+155.0% +$272K
$448K
Debt Issued
—
Debt Repaid
—
D&A↑+4.9% +$2K
$53K
SBC Allocated Expense↑+155.0% +$272K
$448K
SBC Unrecognized Cost
—